During the past decade, Federal State Budgetary Institution conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Federal State Budgetary Institution" #1 sponsor was "Pfizer" with 3 trials, followed by "Materia Medica Holding" with 2 trials sponsored, "Alexion" with 1 trials sponsored, "American Regent, Inc." with 1 trials sponsored and "Ascendis Pharma A/S" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Federal State Budgetary Institution" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Federal State Budgetary Institution" are "Acute Upper Respiratory Tract Infections" (1 trials), "Ankylosing Spondylitis" (1 trials), "CML - Philadelphia Chromosome" (1 trials), "CML, Chronic Phase" (1 trials) and "CML, Refractory" (1 trials). Many other conditions were trialed in "Federal State Budgetary Institution" in a lesser frequency.

Most popular intervention types in "Federal State Budgetary Institution" are "Drug" (12 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ergoferon" (2 trials), "ACP-001" (1 trials), "CXA-101/ tazobactam and metronidazole" (1 trials) and "Cefepime" (1 trials). Other intervention names were less common.

The vast majority of trials in "Federal State Budgetary Institution" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Federal State Budgetary Institution". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Federal State Budgetary Institution, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Federal State Budgetary Institution, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".